#chemotherapy — Tuesday, September 22, 2026 (2 items)
| 0 | ℹ |
Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial.
(linkinghub.elsevier.com)
|
Lancet Infectious Diseases 2026-09-22 | #chagas #clinical trial #parasitology #chemotherapy #antiparasitic | |
| 0 | ℹ |
Trastuzumab plus nivolumab with gemcitabine and cisplatin as first-line therapy for HER2-positive unresectable biliary tract cancer: a phase 1b/2 trial.
(nature.com)
|
Nature Medicine 2026-09-22 | #cancer #clinical trial #immunotherapy #chemotherapy #her2 |